Structure, regulation and function of PKB/AKT - A major therapeutic target

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1697, Issue 1-2, 2004, Pages 3-16

  Hanada, Masahito ^a   Feng, Jianhua ^a   Hemmings, Brian A ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

AGC kinase; AMP activated protein kinase; AMPK; B cell leukaemia lymphoma; Bcl; Cdk; CTMP; Cyclin dependent kinase; Growth factor; Insulin; Phosphorylation; PI3 kinase; PKA, PKG and PKC related kinase; PKB Akt; Signal transduction

Indexed keywords

ANDROGEN RECEPTOR; BINDING PROTEIN; CARBOXY TERMINAL MODULATOR PROTEIN; CASPASE 9; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKERATIN 10; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PDK 1 PROTEIN; PROTEIN; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN GRB 10; PROTEIN KINASE B; PROTEIN P53; SERINE; T CELL LEUKEMIA 1 PROTEIN; TRANSCRIPTION FACTOR; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CATALYSIS; CONFERENCE PAPER; CRYSTAL STRUCTURE; DELETION MUTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; HUMANS; INSULIN; ISOENZYMES; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 1542328927     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2003.11.009     Document Type: Conference Paper

References (149)

1. Jones P.F., Jakubowicz T., Pitossi F.J., Maurer F., Hemmings B.A. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4171-4175.
2. Coffer P.J., Woodgett J.R. Molecular cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur. J. Biochem. 201:1991;475-481.
3. Bellacosa A., Testa J.R., Staal S.P., Tsichlis P.N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 254:1991;274-277.
4. Cheng J.Q., Godwin A.K., Bellacosa A., Taguchi T., Franke T.F., Hamilton T.C., Tsichlis P.N., Testa J.R. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. U. S. A. 89:1992;9267-9271.
5. Brodbeck D., Cron P., Hemmings B.A. A human protein kinase Bγ with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J. Biol. Chem. 274:1999;9133-9136.
6. Yang Z.Z., Tschopp O., Hemmings-Mieszczak M., Feng J., Brodbeck D., Perentes E., Hemmings B.A. Protein kinase Bα/Akt1 regulates placental development and fetal growth. J. Biol. Chem. 278:2003;32124-32131.
7. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14:2002;381-395.
8. Whiteman E.L., Cho H., Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13:2002;444-451.
9. Tyers M., Rachubinski R.A., Stewart M.I., Varrichio A.M., Shorr R.G.L., Haslam R.R.J., Harley C.B. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 333:1988;470-473.
10. Frech M., Andjelkovic M., Ingley E., Reddy K.K., Falck J.R., Hemmings B.A. High affinity binding of inositol phosphates and phosphoinositides to the Pleckstrin homology domain of RAC protein kinase B and their influence on kinase activity. J. Biol. Chem. 272:1997;8474-8481.
11. James S.R., Downes C.P., Gigg R., Grove S.J.A., Holmes A.B., Alessi D.R. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem. J. 315:1996;709-713.
12. Thomas C.C., Deak M., Alessi D.R., van Aalten D.M. High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr. Biol. 12:2002;1256-1262.
13. Peterson R.T., Schreiber S.L. Kinase phosphorylation: keeping it all in the family. Curr. Biol. 9:1999;R521-R524.
14. Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., Cron P., Cohen P., Lucocq J.M., Hemmings B.A. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272:1997;31515- 31524.
15. Brodbeck D., Hill M.M., Hemmings B.A. Two splice variants of protein kinase B γ have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain. J. Biol. Chem. 276:2001;29550-29558.
16. Konishi H., Kuroda S., Tanaka M., Matsuzaki H., Ono Y., Kameyama K., Haga T., Kikkawa U. Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and β, γ subunits of G proteins. Biochem. Biophys. Res. Commun. 216:1995;526-534.
17. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
18. Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell. 9:2002;1227-1240.
19. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C.P., Alessi D.R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9:1999;393-404.
20. Yang J., Cron P., Good V.M., Thompson V., Hemmings B.A., Barford D. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol. 9:2002;940-944.
21. Knighton D.R., Zheng J., Ten Eyck L.F., Ashford V.A., Xuong N.-H., Taylor S.S., Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253:1991;407-413.
22. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:2001;657-664.
23. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
24. Burgering B., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
25. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
26. Kohn A.D., Kovacina K.S., Roth R.A. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14:1995;4288-4295.
27. Chan T.O., Rittenhouse S.E., Tsichlis P.N. Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu. Rev. Biochem. 68:1999;965-1014.
28. Chan T.O., Rittenhouse S.E., Tsichlis P.N. Phosphoinositide 3-kinase signalling - which way to target? Trends Pharmacol. Sci. 24:2003;366-376.
29. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:1998;13375-13378.
30. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39.
31. Rohrschneider L.R., Fuller J.F., Wolf I., Liu Y., Lucas D.M. Structure, function, and biology of SHIP proteins. Genes Dev. 14:2000;505-520.
32. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell. 109:2002;275-282.
33. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα Curr. Biol. 7:1997;261-269.
34. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B., Gaffney P.R., Reese C.B., McCormick F., Tempst P., Coadwell J., Hawkins P.T. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 279:1998;710-714.
35. Biondi R.M., Cheung P.C., Casamayor A., Deak M., Currie R.A., Alessi D.R. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA. EMBO J. 19:2000;979-988.
36. Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C., Hemmings B.A., Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science. 279:1998;707-710.
37. Anderson K.E., Coadwell J., Stephens L.R., Hawkins P.T. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr. Biol. 8:1998;684-691.
38. Williams M.R., Arthur J.S., Balendran A., Van Der K.J., Poli V., Cohen P., Alessi D.R. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:2000;439-448.
39. Biondi R.M., Kieloch A., Currie R.A., Deak M., Alessi D.R. The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J. 20:2001;4380-4390.
40. Collins B.J., Deak M., Arthur J.S., Armit L.J., Alessi D.R. In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J. 22:2003;4202-4211.
41. Hill M.M., Andjelkovic M., Brazil D.P., Ferrari S., Fabbro D., Hemmings B.A. Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J. Biol. Chem. 276:2001;25643-25646.
42. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336:1998;241-246.
43. Delcommenne M., Tan C., Gray V., Ruel L., Woodgett J., Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11211-11216.
44. Persad S., Attwell S., Gray V., Mawji N., Deng J.T., Leung D., Yan J., Sanghera J., Walsh M.P., Dedhar S. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase. J. Biol. Chem. 276:2001;27462-27469.
45. Lynch D.K., Ellis C.A., Edwards P.A., Hiles I.D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene. 18:1999;8024-8032.
46. Hill M.M., Feng J., Hemmings B.A. Identification of a plasma membrane raft-associated PKB ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12:2002;1251-1255.
47. Sakai T., Li S., Docheva D., Grashoff C., Sakai K., Kostka G., Braun A., Pfeifer A., Yurchenco P.D., Fassler R. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17:2003;926-940.
48. Toker A., Newton A.C. Akt/Protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275:2000;8271-8274.
49. Laine J., Kunstle G., Obata T., Sha M., Noguchi M. The protooncogene TCL1 is an Akt kinase coactivator. Mol. Cell. 6:2000;395-407.
50. Chen R., Kim O., Yang J., Sato K., Eisenmann K.M., McCarthy J., Chen H., Qiu Y. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:2001;31858-31862.
51. Jiang T., Qiu Y. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J. Biol. Chem. 278:2003;15789- 15793.
52. Conus N.M., Hannan K.M., Cristiano B.E., Hemmings B.A., Pearson R.B. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 277:2002;38021-38028.
53. Brazil D.P., Park J., Hemmings B.A. PKB binding proteins. Getting in on the Akt. Cell. 111:2002;293-303.
54. Maira S.M., Galetic I., Brazil D.P., Kaech S., Ingley E., Thelen M., Hemmings B.A. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science. 294:2001;374-380.
55. Ferrell J.E. Jr. What do scaffold proteins really do? Sci. STKE. 2000;PE1.
56. Kim A.H., Yano H., Cho H., Meyer D., Monks B., Margolis B., Birnbaum M.J., Chao M.V. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 2002;697-709.
57. Barthwal M.K., Sathyanarayana P., Kundu C.N., Rana B., Pradeep A., Sharma C., Woodgett J.R., Rana A. Negative regulation of mixed lineage kinase 3 by protein kinase B/AKT leads to cell survival. J. Biol. Chem. 278:2003;3897-3902.
58. Figueroa C., Tarras S., Taylor J., Vojtek A.B. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J. Biol. Chem. 278:2003;47922-47927.
59. Huelsken J., Behrens J. The Wnt signalling pathway. J. Cell Sci. 115:2002;3977-3978.
60. Fukumoto S., Hsieh C.M., Maemura K., Layne M.D., Yet S.F., Lee K.H., Matsui T., Rosenzweig A., Taylor W.G., Rubin J.S., Perrella M.A., Lee M.E. Akt participation in the wnt signaling pathway through Dishevelled. J. Biol. Chem. 276:2001;17479-17483.
61. Yuan H., Mao J., Li L., Wu D. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J. Biol. Chem. 274:1999;30419-30423.
62. Konishi H., Matsuzaki H., Tanaka M., Takemura Y., Kuroda S., Ono Y., Kikkawa U. Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett. 410:1997;493-498.
63. Rane M.J., Pan Y., Singh S., Powell D.W., Wu R., Cummins T., Chen Q., McLeish K.R., Klein J.B. Heat shock protein 27 controls apoptosis by regulating Akt activation. J. Biol. Chem. 278:2003;27828-27835.
64. Richter K., Buchner J. Hsp90: chaperoning signal transduction. J. Cell. Physiol. 188:2001;281-290.
65. Sato S., Fujita N., Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10832-10837.
66. Basso A.D., Solit D.B., Chiosis G., Giri B., Tsichlis P., Rosen N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277:2002;39858-39866.
67. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., Burrows F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature. 425:2003;407-410.
68. Han D.C., Shen T.L., Guan J.L. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene. 20:2001;6315-6321.
69. Jahn T., Seipel P., Urschel S., Peschel C., Duyster J. Role for the adaptor protein Grb10 in the activation of Akt. Mol. Cell. Biol. 22:2002;979-991.
70. Paramio J.M., Segrelles C., Ruiz S., Jorcano J.L. Inhibition of protein kinase B (PKB) and PKCζ mediates keratin K10-induced cell cycle arrest. Mol. Cell. Biol. 21:2001;7449-7459.
71. Gold M.R. Akt is TCL-ish: implications for B-cell lymphoma. Trends Immunol. 24:2003;104-108.
72. Pekarsky Y., Koval A., Hallas C., Bichi R., Tresini M., Malstrom S., Russo G., Tsichlis P., Croce C.M. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3028-3033.
73. Du K., Herzig S., Kulkarni R.N., Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 300:2003;1574-1577.
74. Alessi D.R., Caudwell F.B., Andjelkovi M., Hemmings B.A., Cohen P. Molecular basis for the substrate specificity of protein kinase B: comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:1996;333-338.
75. Obata T., Yaffe M.B., Leparc G.G., Piro E.T., Maegawa H., Kashiwagi A., Kikkawa R., Cantley L.C. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275:2000;36108-36115.
76. Kitamura T., Kitamura Y., Kuroda S., Hino Y., Ando M., Kotani K., Konishi H., Matsuzaki H., Kikkawa U., Ogawa W., Kasuga M. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol. Cell. Biol. 19:1999;6286-6296.
77. Deprez J., Vertommen D., Alessi D.R., Hue L., Rider M.H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272:1997;17269-17275.
78. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell. 103:2000;253-262.
79. Nave B.T., Ouwens M., Withers D.J., Alessi D.R., Shepherd P.R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344:1999;427-431.
80. Scott P.H., Brunn G.J., Kohn A.D., Roth R.A., Lawrence J.C. Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signalling pathway. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7772-7777.
81. Sekulic A., Hudson C.C., Homme J.L., Yin P., Otterness D.M., Karnitz L.M., Abraham R.T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:2000;3504-3513.
82. Krymskaya V.P. Tumour suppressors hamartin and tuberin: intracellular signalling. Cell. Signal. 15:2003;729-739.
83. Inoki K., Li Y., Zhu T., Wu J., Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:2002;648-657.
84. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. 10:2002;151-162.
85. Dan H.C., Sun M., Yang L., Feldman R.I., Sui X.M., Ou C.C., Nellist M., Yeung R.S., Halley D.J., Nicosia S.V., Pledger W.J., Cheng J.Q. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277:2002;35364-35370.
86. Ravichandran L.V., Chen H., Li Y., Quon M.J. Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor. Mol. Endocrinol. 15:2001;1768-1780.
87. Downward J. How BAD phosphorylation is good for survival. Nat. Cell Biol. 1:1999;E33-E35.
88. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:1997;687-689.
89. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
90. Trencia A., Perfetti A., Cassese A., Vigliotta G., Miele C., Oriente F., Santopietro S., Giacco F., Condorelli G., Formisano P., Beguinot F. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol. Cell. Biol. 23:2003;4511-4521.
91. Donepudi M., Grutter M.G. Structure and zymogen activation of caspases. Biophys. Chemist. 101-102:2002;145-153.
92. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
93. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912.
94. Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:2001;893-901.
95. Park H.S., Kim M.S., Huh S.H., Park J., Chung J., Kang S.S., Choi E.J. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation. J. Biol. Chem. 277:2002;2573-2578.
96. Paradis S., Ruvkun G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12:1998;2488-2498.
97. Paradis S., Ailion M., Toker A., Thomas J.H., Ruvkun G. A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev. 13:1999;1438-1452.
98. Rena G., Guo S., Cichy S.C., Unterman T.G., Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274:1999;17179-17183.
99. Biggs W.H. III, Meisenhelder J., Hunter T., Cavenee W.K., Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7421-7426.
100. Wolfrum C., Besser D., Luca E., Stoffel M. Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. U. S. A. 100:2003;11624-11629.
101. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
102. Kops G.J., de Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 398:1999;630-634.
103. Burgering B.M., Medema R.H. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73:2003;689-701.
104. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev., Immunol. 2:2000;725-734.
105. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
106. Kane L.P., Mollenauer M.N., Xu Z., Turck C.W., Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-κ B-dependent transcription. Mol. Cell. Biol. 22:2002;5962-5974.
107. Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273:1998;32377-32379.
108. He Y.W. Orphan nuclear receptors in T lymphocyte development. J. Leukoc. Biol. 72:2002;440-446.
109. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J., Croce C.M. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3690-3694.
110. Masuyama N., Oishi K., Mori Y., Ueno T., Takahama Y., Gotoh Y. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J. Biol. Chem. 276:2001;32799-32805.
111. Lin H.K., Yeh S., Kang H.Y., Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7200-7205.
112. Basu S., Totty N.F., Irwin M.S., Sudol M., Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell. 11:2003;11-23.
113. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13:2003;65-70.
114. Zhou B.P., Liao Y., Xia W., Spohn B., Lee M.H., Hung M.C. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:2001;245-252.
115. Rossig L., Jadidi A.S., Urbich C., Badorff C., Zeiher A.M., Dimmeler S. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21:2001;5644-5657.
116. Li Y., Dowbenko D., Lasky L.A. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J. Biol. Chem. 277:2002;11352-11361.
117. Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A., Fusco A., Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:2002;1136-1144.
118. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., Lee J.H., Ciarallo S., Catzavelos C., Beniston R., Franssen E., Slingerland J.M. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:2002;1153-1160.
119. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8:2002;1145-1152.
120. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev., Cancer. 2:2002;594-604.
121. Shimizu H., Hupp T.R. Intrasteric regulation of MDM2. Trends Biochem. Sci. 28:2003;346-349.
122. Mayo L.D., Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11598-11603.
123. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3:2001;973-982.
124. Ashcroft M., Ludwig R.L., Woods D.B., Copeland T.D., Weber H.O., MacRae E.J., Vousden K.H. Phosphorylation of HDM2 by Akt. Oncogene. 21:2002;1955-1962.
125. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., Gotoh Y. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 277:2002;21843-21850.
126. Suzuki A., Kusakai G., Kishimoto A., Lu J., Ogura T., Lavin M.F., Esumi H. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J. Biol. Chem. 278:2003;48-53.
127. Okumura E., Fukuhara T., Yoshida H., Hanada S.S., Kozutsumi R., Mori M., Tachibana K., Kishimoto T. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat. Cell Biol. 4:2002;111-116.
128. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
129. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 400:1999;792.
130. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 399:1999;601-605.
131. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., de Montellano P.R., Kemp B.E., Pearson R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9:1999;845-848.
132. Mercer K.E., Pritchard C.A. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta. 1653:2003;25-40.
133. Zimmermann S., Moelling K. Phosphorylation and regulation of raf by akt (protein kinase B). Science. 286:1999;1741-1744.
134. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., Glass D.J. Differentiation stage-specific inhibition of the raf-MEK-ERK pathway by Akt. Science. 286:1999;1738-1741.
135. Babior B.M., Lambeth J.D., Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397:2002;324-342.
136. Chen Q., Powell D.W., Rane M.J., Singh S., Butt W., Klein J.B., McLeish K.R. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J. Immunol. 170:2003;5302-5308.
137. Hoyal C.R., Gutierrez A., Young B.M., Catz S.D., Lin J.H., Tsichlis P.N., Babior B.M. Modulation of p47PHOX activity by site-specific phosphorylation: Akt-dependent activation of the NADPH oxidase. Proc. Natl. Acad. Sci. U. S. A. 100:2003;5130-5135.
138. Liu Y., Rohrschneider L.R. The gift of Gab. FEBS Lett. 515:2002;1-7.
139. Lynch D.K., Daly R.J. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21:2002;72-82.
140. Takuwa Y., Okamoto H., Takuwa N., Gonda K., Sugimoto N., Sakurada S. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol. Cell. Endocrinol. 177:2001;3-11.
141. Lee M.J., Thangada S., Paik J.H., Sapkota G.P., Ancellin N., Chae S.S., Wu M., Morales-Ruiz M., Sessa W.C., Alessi D.R., Hla T. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell. 8:2001;693-704.
142. McKernan R.M., Whiting P.J. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
143. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wan Y., Liu F., Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron. 38:2003;915-928.
144. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet. 361:2003;1642-1644.
145. Humbert S., Bryson E.A., Cordelieres F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntington phosphorylation by Akt. Dev. Cell. 2:2002;831-837.
146. Humbert S., Saudou F. Toward cell specificity in SCA1. Neuron. 34:2002;669-670.
147. Chen H.K., Fernandez-Funez P., Acevedo S.F., Lam Y.C., Kaytor M.D., Fernandez M.H., Aitken A., Skoulakis E.M., Orr H.T., Botas J., Zoghbi H.Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 113:2003;457-468.
148. Crews S.T. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev. 12:1998;607-620.
149. Jin J., Anthopoulos N., Wetsch B., Binari R.C., Isaac D.D., Andrew D.J., Woodgett J.R., Manoukian A.S. Regulation of Drosophila tracheal system development by protein kinase B. Dev. Cell. 1:2001;817-827.